<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01434953</url>
  </required_header>
  <id_info>
    <org_study_id>AAAC6382</org_study_id>
    <nct_id>NCT01434953</nct_id>
  </id_info>
  <brief_title>Prehypertension Labeling</brief_title>
  <acronym>Tanya K23</acronym>
  <official_title>Diagnostic Labeling: Effect on White Coat Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Columbia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Columbia University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to find out whether labeling adults with prehypertension has
      negative effects on clinic blood pressure and quality of life 3 months after diagnosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Previous research has shown that a diagnosis of hypertension is associated with subsequent
      increases in resting blood pressure, and there is preliminary evidence of a cross-sectional
      association between hypertension labeling and the white coat effect. The white coat effect
      may be particularly problematic in prehypertensives, because a small elevation in clinic
      blood pressure could result in crossing the diagnostic cutoff for hypertension, potentially
      leading to misdiagnosis and unnecessary treatment. This study will examine effects of
      prehypertension labeling on clinic and ambulatory blood pressure, and will examine potential
      psychological mediators of these associations.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    PI left institution
  </why_stopped>
  <start_date type="Actual">July 13, 2009</start_date>
  <completion_date type="Actual">July 9, 2012</completion_date>
  <primary_completion_date type="Actual">July 9, 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in blood pressure</measure>
    <time_frame>Baseline, 3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in health-related quality of life (SF-12 questionnaires)</measure>
    <time_frame>Baseline, 3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Prehypertension</condition>
  <arm_group>
    <arm_group_label>Labeled</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Unlabeled</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Labeled prehypertension</intervention_name>
    <description>A study physician informs subjects of their blood pressure level. Subjects are told they have prehypertension and are informed of the associated health risks.</description>
    <arm_group_label>Labeled</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Unlabeled prehypertension</intervention_name>
    <description>A study physician informs subjects of their blood pressure level. The term &quot;prehypertension&quot; is not used and associated health risks are not discussed.</description>
    <arm_group_label>Unlabeled</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  at least 18 years

          -  average screening systolic blood pressure of 120-139 mmHg OR diastolic blood pressure
             of 80-89 mmHg

          -  average screening systolic blood pressure below 140 mmHg AND diastolic blood pressure
             below 90 mmHg

          -  able to read and write in English

        Exclusion Criteria:

          -  past diagnosis of hypertension, prehypertension, or high blood pressure

          -  current or past use of antihypertensive medications

          -  diabetes

          -  renal disease

          -  cardiovascular disease

          -  current participation in another hypertension-related clinical trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matthew Burg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Columbia University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 8, 2011</study_first_submitted>
  <study_first_submitted_qc>September 14, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 15, 2011</study_first_posted>
  <last_update_submitted>July 13, 2017</last_update_submitted>
  <last_update_submitted_qc>July 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Prehypertension</keyword>
  <keyword>Blood pressure screening</keyword>
  <keyword>White coat effect</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prehypertension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

